Delivery Order SPE2DB24D2011-SPE2DB24FBPCE
Award Date 3/26/24
Potential Completion Date 3/27/24
Potential Value $42K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4564109711 - TRULICITY 0.75 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $1,978.32 and a period of performance through March 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563471835 - TRULICITY 0.75 MG/0.5 ML PEN 0.5ML. The contract has a potential value of $2,902.80 and a completion date of January 30, 2024. This is not a set-aside contract. Amerisourcebergen Drug Corp is the prime contractor and will perform the work at its corporate office in Conshohocken, Pennsylvania. This...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the medication TRULICITY 0.75 MG/0.5 ML PEN 0.5ML. The contract, valued at $2,283.17, has an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of TRULICITY 0.75 mg/0.5 ml pens. The $7,965.65 contract has an ultimate completion date of April 2, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as...
- The U.S. Defense Logistics Agency (DLA) awarded a $10,206.72 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML pharmaceuticals. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $3,483.36 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML. This award is part of Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $8,708.40 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00, which serves as the primary contract vehicle for the company to deliver pharmaceuticals and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4564134372 TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. This $25,454.34 award under contract SPE2DB24D2011|SPE2DB24FBPEE has an ultimate completion date of April 2, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) from DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TRULICITY 0.75 MG/0.5 ML PEN 0.5ML pharmaceuticals. The contract has a potential value of $2,760.96 and a completion date of January 29, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide TRULICITY 0.75 MG/0.5 ML PEN 0.5ML pharmaceuticals. The $3,483.36 order has a completion date of January 9, 2024. AmerisourceBergen Drug Corp is the prime contractor and serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities...
- SPE2DB24D2011Indefinite Delivery Contract
- SPE2DB24D2011-SPE2DB24FBPCEDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4564084875 – TRULICITY 0.75 MG/0.5 ML PEN 0.5ML. The award, valued at $42,065.01, has a performance period through March 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this specific delivery order.
Generated 6/25/24, 1:58 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $42.1k | 3/26/24 |